Medical Hypotheses
Volume 59, Issue 6 , Pages 660-666 , 12 November 2002

A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis

  • S.R Kim

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    • Corresponding Author InformationCorrespondence to: S. R. Kim, 102 Woodshire Dr, Pittsburgh, PA 15215, USA
    • ,
  • E.S Tull

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    • ,
  • E.O Talbott

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    • ,
  • M.T Vogt

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    • Department of Orthopedic Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    • ,
  • L.H Kuller

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Received 15 May 2001 ,Accepted 11 January 2002.

References 

  1. De Fronzo RA, Tobin JD, Andres R. Glucose clamp techniques: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979;237:E214–E223
  2. Rewers M, Hanmman RF. Risk factors for NIDDM. In: Diabetes in America. 2nd Edn.. 1995;p. 179–220
  3. Pilkis SJ, El-Maghrabi MR, Claus TH. Fructose-2,3-biphosphate in control of hepatic gluconeogenesis: from metabolites to molecular genetics. Diabetes Care. 1990;13:588–599
  4. Groop IC, Kaankuri M, Schalin JC. Association between polymorphism of the glycogen synthase gene and NIDDM. N. Engl. J. Med. 1993;328:110–114
  5. Sherrat HAS, Bartlett K. Metabolic regulation. In:  Cohen RD,  Lewis B,  Albert KGMM,  Denmann AM editor. The Metabolic and Molecular Basis of Acquired Diseases. London: Baillie’re Tindall; 1990;p. 300–320
  6. Groot LJ, Jameson JL. Mechanism of thyroid hormone action. In: Endocrinology. 3rd Edn.. Leslie Degroot, Philadelphia, PA: W. B. Saunders; 1995;p. 1–64 pp. 583–601
  7. Granner DK, Pikis S. The genes of hepatic glucose metabolism. J. Biol. Chem. 1990;265:10173–10182
  8. Weinstein SP, Watts J, Graves PN, Haber RS. Stimulation of glucose transport by thyroid hormone in ARL.15 cells: increased abundance of glucose transporter protein and messenger RNA. Endocrinology. 1990;126:1421–1429
  9. Meyers DS, Skwish S, Kenneth EJ, Kienzle DB, Arbeeny C. 3-Adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomologus monkeys. J. Clin. Endocrinol. Metab. 1997;82:395–401
  10. Garcia-Sainz A, Litosch I, Hoffman B. Effect of thyroid state on a- and b-cathecholamine responsiveness of hamster. Biochim. Biphys. Acta. 1981;678:334–341
  11. Pan DA, Lilliolja S, Krikrtos AD, Miller MR, Bauer LA, Borgadus C. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 1997;83–988
  12. Rapiejko PJ, Watkins DC, Ros M, Malbon CC. Thyroid hormones regulate G-protein B subunit mRNA expression in Vivo. J. Biol. Chem. 1989;264:16183–16189
  13. Randle PJ, et al.  Concept of the glucose-fatty acid cycle. Ciba Found. Colloquia Endocrinol. 1964;15–19
  14. Kelly ED, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance. Diabetes. 2000;49:677–683
  15. Verhaegen M, Mariash CN, Krug F. Nunez: cyclic AMP and lipogenesis in fat cells from thyroidectomized rats. J. Mol. Cell. Endocrinol. 1979;14:167–169
  16. Freake HC, Schwartz HL, Oppenheimer JH. The regulation of lipogenesis and its contribution to thermogenesis. Endocrinology. 1989;125:2868–2874
  17. Melbone CC, Moreno FJ, Cabell RJ, Fain JN. Cyclic nucleotides and lipogenesis in fat cell from thyroidectomized rats. J. Biol. Chem. 1978;253:671–678
  18. Forciea M. A., Schwartz H. L., Towle H. C., Mariash C. N., Kaiser F. E., Oppenheimer J. H. Thyroid hormone-carbohydrate interaction in rat. 67: 1739–1747
  19. O’Brien RM, Watson R. Regulation of fetal muscle development by thyroxin. Acta Anat. 1994;149(1):21–30
  20. Pittman CS. The effects of diabetes mellitus on thyroid physiology. Thyroid Today. 1981;4:1–4
  21. Ohara H, Kobayshi , Shiraishi M, Wada T. Thyroid function of the aged as viewed from the pituitary thyroid system. Endocrinol. JPN. 1979;21:377–384
  22. Lewis GF, Alessi CA, Imperial JG, Refetoff S. Low serum thyroxin index in ambulatory elderly is due to a resetting of the threshold of thyrotropin feedback suppression. J. Clin. Endocrinol. Metabolism. 1991;972X:0843–7304
  23. Segal J, Ingbar SH. In vivo stimulation of sugar uptake in rat thymocyte. J. Clin. Inv. 1985;76:1575–1580
  24. Gilman AG. G-proteins and dual control of adenylate cyclase. Cell. 1984;36(40):577–579
  25. Styler L, Bourne HR. G-proteins: a family of signal transducers. Ann. Rev. Cell. Biol. 1986;2:391–419
  26. Khalfallah Y, Fages S, LAviile M. Regulation of UCP-2 and 3 mRNA expression during lipid infusion in human skeletal muscle and subcutaneous adipose tissue. Diabetes. 2000;49:25–31
  27. Boss O, Hagen T, Lowell BB. Uncoupling proteins 2 and 3; potential regulators of mitochondrial energy metabolism. Diabetes. 2000;49:143–156
  28. Pendersen O. Decreased tolbutamide-stimulated insulin secretion in healthy subjets with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes. 1998;47:598–605
  29. Agular-Bryan J. Molecular biology of ATP-sensitive potassium channels. Endocr. Res. 1999;20:101–136
  30. Orlowsky J, Lingrell JB. Thyroid and glucocorticoid homornes regulate the expression of multiple Na, K-ATPase genes in cultured neonatal rat cardiac myocytes. J. Bio. Chem. 1990;265:3462–3470
  31. Subramaniant A, Jones WK, Gulick J, Wert S, Neuman J, Robbins J. Tissue-specific regulation of the a-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 1991;256:24613–24620
  32. Houselay MD, Kilgour E. Cyclic nucleotide phosphodiesterase in liver. In:  Beavo JA,  Houselay MD editor. Cycleic Nucleotide Phosphodiesterase: Structure, Regulation and Drug Action. Chichester, UK: Wiley; 1990;p. 185–223
  33. Kitabchi AE, Umpierrez GE, Murphy MB, Barret EJ. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24:131–151
  34. Raasmaja A, Larsen PR. A1 and B-adrenergi agents cause synergistic stimulation of the lodothyronine Deiodinase in rat brown adiposities. Endocrinology. 1989;125:2502–2509 1999
  35. Revell VP, Pescini R, Muzzin P, Seydoux J. Change in B1- and B2-adrenergic receptor mRNA levels in brown adipose tissue and heart of hypothyroid rats. Biochem. J. 1991;277:625–629
  36. Sharp GW. The adenylate cyclase-cAMP system in islets of Langerhans and its role in the control of insulin release. Diabetologia. 1979;16:287–296
  37. Sheja L, Makowski L, Uysal KT. Altered insulin secretion associated with reduced lipolytic efficiency in a P2−/− mice. Diabetes. 48:1987-1994;
  38. Philip DL, Caddy S, Illic V, Fielding BA, Frayn KN, Borth wick AC. Intramuscular triglyceride and muscle insulin sensitivity: evidence for relationship in nondiabetic subjects. Metabolisms. 1996;45:947–950
  39. Kyte J. Molecular considerations relevant to the mechanism of active transport. Nature. 1981;292:201–204
  40. Hoppner W, Seitz HJ. Effect of thyroid hormones on glucokinase gene transcription in rat liver. J. Biol. Chem. 1989;264:20647
  41. Wall SR, van den MF. Thyroid hormone stimulates expression of6-phosphofructo-2-kinase in rat liver. FEBS Lett. 1989;267:211–214
  42. Swierczyski J, Mitchell DA, Reinhold DS. Triiodothyronine-induced accumulations of malic enzyme, fatty acid synthase, acetyl-coA carboxylase, and their mRNAs are blocked by protein kinase inhibitors. Transcription is the affected step. J. Biol. Chem. 1991;266:17459–17466
  43. Simonet WS, Ness GC. Transcriptional and posttranscriptional regulation of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase by thyroid hormone receptor. Proc. Natl. Acad. Sci. USA. 1987;84:3420–3425
  44. Strobl W, Gorder NL, Lin Ly, et al.  Role of thyroid hormones in apolipoprotein A-1 gene expression in rat liver. J. Clin. Invest. 1990;85:659–667
  45. Thomson AL, Cooney GJ. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. Diabetes. 2000;49:1761–1765
  46. Goodpaster BH, Theate FL, Slmoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes. 1997;46:1579–1595
  47. Olesky J. M., Farquhar J. W., Raven G. M. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57: 551–560
  48. Redgrave TG, Snibson DA. Clearance of chylomicron triacylglycerol and cholesteryl ester from plasma of streptozin-induced diabetic and hypercholesterolemic hypothyroid rats. Metabolism. 1977;26:493–503
  49. Hiroes YH, Lindsey RL, Yoshitaka N, Johnson JH, Unger RH. Defective fatty acid-mediated b-cell compensation in Zucker diabetic fatty acid rate pathogenic implication for obesity-dependent diabetes. J. Biol. Chem. 1996;217:5633–5637
  50. Shupnik Ardissen LJ, Meskell MJ. T3 regulation of TSH subunit gene transcription is proportional to T3 nuclear receptor occupancy. Endocrinology. 1986;118:367–371
  51. Weyer C, Borgadus C, Pratley EP. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose. Diabetes. 1999;48:2197–2203
  52. Barter P, Miller1 , Larruoy D, Galitky J, Berdan M, Louvert JP, et al. Uncoulping proteins 2mRNA expression during very-low-calorie-diet in obese premenopausal women. J. Clin. Endocrinol. Metab. 1998;83:2450–2453
  53. Schrauen P, Xia J, Bogardus C, Partley RE, Ravissen E. Skeletal muscle uncoupling protein3 expression is a determination of energy expenditure in Pima Indians. Diabetes. 1999;48:146–149
  54. Nyholin B, Qu Z, Kaal A. Evidence of an increased number of type-2b muscle fibers in insulin resistant first-degree relatives of patients with NIDDM. Diabetes. 1997;46:1822–1828
  55. Warrik HM, Spudich JA. Myosin structure and function in cell motility. Ann. Rev. Cell. Biol. 1987;3:379–421
  56. He J, Watkins S, Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes. 2001;50:817–823
  57. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Am. J. Physiol. 1999;277:E1130–E1141
  58. Simoneeau JA, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contributes to insulin resistance in NIDDM. J. Appl. Physiol. 1997;83:166–171
  59. Simoneau JA, Collberg SR, Theate FL, Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities of skeletal muscle composition in obese women. FASEB J. 1996;9273–9278
  60. Kim S. R., Talbott E. O., Tull E. S., Vogt M. T., Kuller L. H. Assessment of metabolic homeostasis. Med. Hypothesis (submitted)

PII: S0306-9877(02)00211-6

Medical Hypotheses
Volume 59, Issue 6 , Pages 660-666 , 12 November 2002

Article Tools

* Image Usage & Resolution